Fight Aging! - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Fight Aging!

Fight Aging!

Publication
0 followers

Personal longevity science blog tracking advances in anti-aging biotechnology, rejuvenation research, and advocacy for life-extension therapies

Recent Posts

Partial Reprogramming of Neurons Encoding Memory Improves Cognitive Function in Aged Mice
News•Feb 19, 2026

Partial Reprogramming of Neurons Encoding Memory Improves Cognitive Function in Aged Mice

Researchers applied cyclic OSK (Oct4‑Sox2‑Klf4) gene therapy to memory‑encoding neurons in aged mice, achieving partial cellular reprogramming without full pluripotency. The intervention reversed senescence‑related gene expression, restored youthful epigenetic patterns, and normalized synaptic plasticity in both hippocampal and prefrontal engrams. In Alzheimer’s‑model mice, the treatment also reduced neuronal hyperexcitability. Across brain regions and behavioral tests, reprogrammed mice performed on par with young, healthy controls, indicating robust cognitive rejuvenation.

By Fight Aging!
Reduced APOE Expression Improves Bone Regeneration in Aged Mice
News•Feb 18, 2026

Reduced APOE Expression Improves Bone Regeneration in Aged Mice

Researchers discovered that elevated circulating APOE in older mice suppresses bone regeneration by inhibiting osteoblast differentiation. Liver‑specific knockout of APOE or a single dose of a neutralizing antibody lowered serum APOE, restored Wnt/β‑catenin signaling, and markedly improved fracture callus density...

By Fight Aging!
IRF7 Expression Drives Instability in Atherosclerotic Plaques
News•Feb 18, 2026

IRF7 Expression Drives Instability in Atherosclerotic Plaques

Researchers identified interferon regulatory factor 7 (IRF7) as a master transcriptional driver that pushes vascular smooth muscle cells (SMCs) into a pro‑inflammatory, macrophage‑like state, a key step in plaque destabilisation. Single‑cell RNA sequencing and trajectory analysis uncovered an intermediate stem‑endothelial‑monocyte...

By Fight Aging!
The Aging of Retinal Vasculature Reflects the Aging of the Brain
News•Feb 17, 2026

The Aging of Retinal Vasculature Reflects the Aging of the Brain

Researchers used UK Biobank data to map vascular phenotypes across the retina, carotid artery, aorta, and brain, revealing consistent cross‑organ correlations. Retinal vascular density showed modest but significant negative links with white‑matter hyperintensities, carotid intima‑media thickness, and aortic lumen size,...

By Fight Aging!
People Are Still Working on the Senolytic Peptide FOXO4-DRI
News•Feb 16, 2026

People Are Still Working on the Senolytic Peptide FOXO4-DRI

FOXO4‑DRI, a peptide that blocks the FOXO4‑p53 interaction, continues to be explored as a senolytic therapy. Recent preclinical work shows that injecting the peptide into aged and progeroid mice reduces endothelial cell senescence and improves aortic function. Companies such as...

By Fight Aging!
Increased O-GlcNAc Transferase Expression as an Approach to Improving Function in the Aging Brain
News•Feb 16, 2026

Increased O-GlcNAc Transferase Expression as an Approach to Improving Function in the Aging Brain

Age‑related decline in O‑GlcNAc Transferase (OGT) activity contributes to neurodegenerative disorders such as Alzheimer’s, Parkinson’s and ALS. Traditional approaches aim to raise O‑GlcNAc levels by inhibiting O‑GlcNAcase, but recent research highlights transcriptional control of OGT as a more direct therapeutic...

By Fight Aging!
Inflammatory Glycogen Produced by Gut Microbes Contributes to Neurodegeneration
News•Feb 16, 2026

Inflammatory Glycogen Produced by Gut Microbes Contributes to Neurodegeneration

Researchers have identified inflammatory glycogen produced by gut microbes as a driver of age‑related neurodegeneration, especially in ALS and frontotemporal dementia linked to C9ORF72 mutations. In germ‑free mice lacking C9ORF72, colonization with glycogen‑producing Parabacteroides merdae triggered monocytosis, blood‑brain barrier breakdown,...

By Fight Aging!
The ARMOR Study of Fecal Microbiota Transplantation to Treat Aging
News•Feb 13, 2026

The ARMOR Study of Fecal Microbiota Transplantation to Treat Aging

The ARMOR study is a double‑blind, placebo‑controlled trial testing oral fecal microbiota transplantation (FMT) from young, physically active donors in adults aged 65‑84. By delivering lyophilized microbiota capsules, the trial aims to restore gut diversity and assess impacts on muscle...

By Fight Aging!
The Ethical Case for the Development of Means to Treat Aging as a Medical Condition
News•Feb 13, 2026

The Ethical Case for the Development of Means to Treat Aging as a Medical Condition

The article argues that aging, the leading cause of human suffering, should be treated as a medical condition, leveraging recent biogerontology breakthroughs that demonstrate its biological malleability. It contends that ethical justification must go beyond cost‑benefit calculations, grounding the case...

By Fight Aging!
Interactions Between Neurons and Glial Cells in the Aging Brain
News•Feb 13, 2026

Interactions Between Neurons and Glial Cells in the Aging Brain

Researchers examined how aging alters neuron‑glia communication in Drosophila, identifying 872 age‑dependent glial surface proteins. Proteins linked to transport increased, while those involved in synapse organization declined. Overexpressing the glial adhesion protein DIP‑β extended both male and female lifespan and...

By Fight Aging!
Position Effect Variegation as a Way to Visualize Age-Related Structural Change of Nuclear DNA
News•Feb 12, 2026

Position Effect Variegation as a Way to Visualize Age-Related Structural Change of Nuclear DNA

Researchers have repurposed position effect variegation (PEV) in Drosophila melanogaster as a visual aging clock that reports age‑dependent loss of heterochromatin. Pericentric insertions show suppressed eye variegation in older flies, indicating chromatin decompaction and increased transcription. Environmental interventions such as...

By Fight Aging!
MTOR Inhibitors Reduce DNA Damage and Consequent Cellular Senescence in Immune Cells
News•Feb 11, 2026

MTOR Inhibitors Reduce DNA Damage and Consequent Cellular Senescence in Immune Cells

Researchers have found that mTOR inhibitors such as rapamycin directly reduce DNA damage in human immune cells, thereby decreasing cellular senescence. The effect was observed in vitro with T cells under genotoxic stress and was not mediated by autophagy, protein...

By Fight Aging!
Endoplasmic Reticulum Autophagy Is Important in Aging
News•Feb 11, 2026

Endoplasmic Reticulum Autophagy Is Important in Aging

Researchers used high‑resolution live imaging in C. elegans, yeast, and mammalian cells to map how the endoplasmic reticulum (ER) remodels during ageing. They observed a universal decline in ER protein content and a shift from dense sheet structures to diffuse...

By Fight Aging!
More Evidence for a Prevalent Accumulation of Aggregated Proteins in the Aging Brain
News•Feb 11, 2026

More Evidence for a Prevalent Accumulation of Aggregated Proteins in the Aging Brain

Researchers identified an "aggregome" of 1,726 proteins that accumulate in the aging mouse brain, with neuronal protein half‑life roughly doubling between 4 and 24 months. The aggregation profile varies across brain regions and is enriched for synaptic proteins. Over half...

By Fight Aging!
A Reinvigorated Alcor and Growth in Cryonics
News•Feb 10, 2026

A Reinvigorated Alcor and Growth in Cryonics

The post highlights Alcor’s recent surge in funding and operational upgrades, marking a turning point for the cryonics sector. New initiatives include the first in‑house whole‑body CT scan for real‑time vitrification assessment, improved organ‑preservation protocols, and pioneering brain‑slice culture experiments....

By Fight Aging!
BDNF Gene Therapy Improves Cognitive Function in Alzheimer's Model Mice
News•Feb 10, 2026

BDNF Gene Therapy Improves Cognitive Function in Alzheimer's Model Mice

Researchers engineered a novel adeno‑associated virus serotype, AAVT42, that shows superior neuronal tropism compared with AAV9. By stereotactically injecting AAVT42‑delivered BDNF into the hippocampus of three Alzheimer’s disease mouse models, they achieved long‑term BDNF expression. This intervention mitigated neuronal loss...

By Fight Aging!
A Technique for Generating Artificial Lymph Nodes
News•Feb 10, 2026

A Technique for Generating Artificial Lymph Nodes

Researchers have introduced a centrifuge‑based bioengineered lymphatic tissue (CeLyT) that merges lymphatic endothelial cells (LECs) with mesenchymal stem/stromal cells (MSCs) using an additive‑free cell‑stacking method. The construct self‑assembles a functional lymphatic network in culture and, after implantation in mice, generates...

By Fight Aging!
Arguing for a Higher Heritability of Human Longevity
News•Feb 6, 2026

Arguing for a Higher Heritability of Human Longevity

A new open‑access study re‑examines human longevity heritability, arguing that previous estimates were biased low because they ignored extrinsic mortality and arbitrary age cutoffs. By modeling and correcting for these factors, the authors find intrinsic lifespan heritability rises to roughly...

By Fight Aging!
CUL5 as a Potential Target to Reduce Tau Levels in the Aging Brain
News•Feb 6, 2026

CUL5 as a Potential Target to Reduce Tau Levels in the Aging Brain

Researchers have identified the ubiquitin ligase CUL5 as a negative regulator of tau protein levels in human neurons. A genome‑wide CRISPR interference screen in iPSC‑derived neurons highlighted CUL5 knockdown as a potent means to lower intracellular tau, echoing similar hits...

By Fight Aging!
Better Understanding How Misfolded Α-Synuclein Moves From Gut to Brain
News•Feb 6, 2026

Better Understanding How Misfolded Α-Synuclein Moves From Gut to Brain

Researchers have identified muscularis macrophages (ME‑Macs) as pivotal carriers of misfolded α‑synuclein in the gut, facilitating its spread to the brain in Parkinson's disease models. Experimental depletion of ME‑Macs markedly reduced α‑synuclein pathology in both the enteric and central nervous...

By Fight Aging!
Perspectives on Aging Research and the Near Future of the Field
News•Feb 5, 2026

Perspectives on Aging Research and the Near Future of the Field

The blog compiles leading scientists' forecasts for aging research over the next decade, highlighting a shift from descriptive studies to therapeutic interventions. Experts anticipate rapid advances in senescent‑cell clearance, epigenetic reprogramming, multi‑omics profiling, and AI‑driven target discovery. Clinical pipelines are...

By Fight Aging!
Sex Differences in Atherosclerotic Cardiovascular Disease
News•Feb 5, 2026

Sex Differences in Atherosclerotic Cardiovascular Disease

A new analysis of the CARDIA cohort spanning 34 years confirms that men experience premature atherosclerotic cardiovascular disease (CVD) several years earlier than women, with a 5% cumulative incidence occurring at age 50.5 versus 57.5 for women. The gap emerges...

By Fight Aging!
Α-Ketoglutarate Interacts with TET to Regulate Cellular Senescence
News•Feb 5, 2026

Α-Ketoglutarate Interacts with TET to Regulate Cellular Senescence

A recent human trial of α‑ketoglutarate (AKG) supplementation failed to demonstrate measurable health benefits, prompting renewed focus on pre‑clinical evidence. New cell‑based research shows that the AKG‑TET enzymatic axis governs epigenetic reprogramming that drives or reverses cellular senescence. Down‑regulating AKG...

By Fight Aging!
Functional Amyloids Are Involved in Long Term Memory
News•Feb 4, 2026

Functional Amyloids Are Involved in Long Term Memory

Researchers have identified a Drosophila chaperone, named Funes (CG10375), that promotes the formation of functional amyloids essential for long‑term memory. Funes interacts with the prion‑like protein Orb2, driving its amyloid conversion at synapses, and flies with elevated Funes retain odor‑reward...

By Fight Aging!
The First Clinical Trial of Partial Reprogramming Will Start Soon
News•Feb 4, 2026

The First Clinical Trial of Partial Reprogramming Will Start Soon

The FDA has cleared Life Bioscience’s ER-100 for the first human trial of partial epigenetic reprogramming, aimed at restoring damaged retinal cells in patients with open‑angle glaucoma and non‑arteritic anterior ischemic optic neuropathy. The therapy delivers three Yamanaka factors—Oct4, Sox2...

By Fight Aging!
Ferroptosis in Alzheimer's Disease Is Reduced by Exercise
News•Feb 4, 2026

Ferroptosis in Alzheimer's Disease Is Reduced by Exercise

Recent review highlights ferroptosis, an iron‑dependent lipid‑peroxidation cell death, as a key driver of neuronal loss in Alzheimer’s disease. Senescent cells disrupt iron homeostasis, antioxidant defenses, and autophagy, creating a pro‑ferroptotic brain environment that accelerates pathology. Physical exercise counteracts these...

By Fight Aging!
Considering Autophagy as a Means to Modestly Slow Aging
News•Feb 3, 2026

Considering Autophagy as a Means to Modestly Slow Aging

Autophagy is the cell’s recycling system that removes damaged proteins and organelles, becoming most active under mild stress such as fasting or exercise. Research shows that enhancing autophagy can modestly extend lifespan and healthspan in animal models. The longevity industry...

By Fight Aging!
Phenotypic Age Predicts Mortality Risk in Parkinson's Disease Patients
News•Feb 3, 2026

Phenotypic Age Predicts Mortality Risk in Parkinson's Disease Patients

The post discusses a new study using the Phenotypic Age (PhenoAge) clock to predict mortality risk in Parkinson's disease (PD) patients, finding that higher PhenoAge and its acceleration are strong independent predictors of death alongside factors like age, male sex,...

By Fight Aging!
A Deeper Investigation of Recent Trends in Life Expectancy
News•Feb 3, 2026

A Deeper Investigation of Recent Trends in Life Expectancy

A new study of 450 sub‑national regions in 13 Western European countries reveals stark regional disparities in life expectancy trends. Researchers identify two distinct phases: a "golden era" from 1992‑2005 with robust gains of roughly 2.5 months per year for...

By Fight Aging!
Exercise as a Way to Enhance DNA Repair to Slow Aging
News•Feb 2, 2026

Exercise as a Way to Enhance DNA Repair to Slow Aging

An open‑access review links regular exercise to enhanced DNA‑repair pathways that may decelerate muscle aging. It outlines two emerging mechanisms: somatic mosaicism from stem‑cell mutations and epigenetic drift driven by repeated double‑strand break repair. The paper highlights how chronic training...

By Fight Aging!
Small RNAs Altered in Human Calorie Restriction
News•Feb 2, 2026

Small RNAs Altered in Human Calorie Restriction

Researchers analyzed small non‑coding RNAs in participants of the CALERIE Phase 2 calorie‑restriction trial, which achieved a 12‑15% reduction in intake over 12‑24 months. Using smRNA sequencing of plasma, muscle, and adipose tissue, they identified 16 RNAs linked to the degree of...

By Fight Aging!
The Γδ T-Cell Population Changes with Age
News•Feb 2, 2026

The Γδ T-Cell Population Changes with Age

A recent mouse study shows that aging dramatically reshapes the peripheral γδ T‑cell compartment, expanding innate‑like subsets that produce higher levels of IL‑17. The age‑associated shift coincides with a marked loss of the transcription factor Foxo1 within these cells. Researchers...

By Fight Aging!
Senolytics as a Treatment for Diabetic Kidney Disease
News•Jan 30, 2026

Senolytics as a Treatment for Diabetic Kidney Disease

Researchers evaluated the senolytic combination dasatinib plus quercetin (D+Q) in diabetic kidney disease models and a pilot human trial. In streptozotocin‑induced diabetic mice, a short five‑day oral regimen reduced kidney injury markers, fibrosis, and the senescence marker p16Ink4a while boosting...

By Fight Aging!
Facial Skin Regenerates with Less Scarring, and the Underlying Mechanism Could Be Applied Elsewhere in the Body
News•Jan 30, 2026

Facial Skin Regenerates with Less Scarring, and the Underlying Mechanism Could Be Applied Elsewhere in the Body

Researchers have uncovered why facial skin heals with less scarring than other body sites. They identified a signaling pathway centered on the protein ROBO2 that keeps facial fibroblasts in a low‑fibrotic state by inhibiting EP300. In mouse models, pharmacologic EP300...

By Fight Aging!
Fecal Microbiota Transplantation From Young Mice to Old Mice Improves Intestinal Stem Cell Function
News•Jan 29, 2026

Fecal Microbiota Transplantation From Young Mice to Old Mice Improves Intestinal Stem Cell Function

A recent study demonstrates that transferring fecal microbiota from young to old mice restores intestinal stem cell (ISC) function by reactivating canonical Wnt signaling. The young‑derived microbiota increased expression of Ascl2 and Lgr5, boosted crypt mitotic activity, and improved regenerative...

By Fight Aging!
Exercise Reduces Inflammatory TMAO Produced by the Gut Microbiome
News•Jan 29, 2026

Exercise Reduces Inflammatory TMAO Produced by the Gut Microbiome

Researchers demonstrated that regular exercise markedly reduces the gut‑derived inflammatory metabolite trimethylamine N‑oxide (TMAO) in an aging rat model, lowering plasma TMAO by roughly 40%. The reduction coincided with significant improvements in cognitive performance, with the discrimination index rising 22.6%...

By Fight Aging!
Bone Targeted Delivery of Mitochondria Wrapped in Artificial Cell Membranes
News•Jan 29, 2026

Bone Targeted Delivery of Mitochondria Wrapped in Artificial Cell Membranes

Researchers have engineered artificial cell microspheres (Fmito@ACs) that encapsulate healthy mitochondria from fetal mouse mesenchymal stem cells, shielding them from degradation in circulation. By applying an external magnetic field, these microspheres can be directed to bone fracture sites, where they...

By Fight Aging!
Reviewing the Role of Mitochondrial Dysfunction in Alzheimer's Disease
News•Jan 28, 2026

Reviewing the Role of Mitochondrial Dysfunction in Alzheimer's Disease

Recent open‑access review argues mitochondrial dysfunction is a central driver of Alzheimer’s disease. The paper highlights altered mitochondrial morphology, reduced mtDNA, and impaired oxidative phosphorylation in AD brains. It proposes mitochondrial transplantation, delivered intrathecally, as a near‑term therapeutic strategy, while...

By Fight Aging!
Greater Prevalence of the Favorable APOE-Ε2 Variant in People with Preserved Cognitive Function
News•Jan 28, 2026

Greater Prevalence of the Favorable APOE-Ε2 Variant in People with Preserved Cognitive Function

Researchers examined APOE allele frequencies in “SuperAgers” versus Alzheimer’s disease patients and typical controls using the ADSP‑PHC multicohort dataset. Among non‑Hispanic White participants, SuperAgers displayed significantly fewer APOE‑ε4 alleles and a higher prevalence of the protective APOE‑ε2 allele compared with...

By Fight Aging!
Heart Disease and Stroke Continue to Account for More than a Quarter of Human Mortality
News•Jan 28, 2026

Heart Disease and Stroke Continue to Account for More than a Quarter of Human Mortality

Heart disease and stroke together accounted for more than a quarter of all U.S. deaths in 2023, remaining the nation’s leading cause of mortality. Although overall death rates are improving post‑COVID, half of American adults still live with some form...

By Fight Aging!
Results From the Immunis Phase 2 Trial of a Stem Cell Secretome Therapy
News•Jan 27, 2026

Results From the Immunis Phase 2 Trial of a Stem Cell Secretome Therapy

Immunis announced interim Phase 2 results for its IMM01‑STEM secretome therapy in 47 obese seniors with muscle loss and metabolic dysfunction. The double‑blind, placebo‑controlled study showed a 26 % improvement in gait speed, a validated marker of overall health. Preclinical data also...

By Fight Aging!
Data Suggests Age-Related RNA Processing Alterations in Sperm Cells
News•Jan 27, 2026

Data Suggests Age-Related RNA Processing Alterations in Sperm Cells

Researchers applied PANDORA‑seq to profile small non‑coding RNAs in mouse and human sperm across the lifespan, uncovering an "aging cliff" marked by abrupt shifts in tRNA‑derived (tsRNA) and rRNA‑derived (rsRNA) small RNAs. In aged sperm heads, rsRNAs lengthened while shorter...

By Fight Aging!
Correlation Between Shingles Vaccination and Measures of Biological Aging
News•Jan 27, 2026

Correlation Between Shingles Vaccination and Measures of Biological Aging

Using data from the U.S. Health and Retirement Study, researchers examined more than 3,800 adults aged 70 and older and found that receipt of the shingles vaccine was linked to slower biological aging across seven biomarkers. Vaccinated participants showed significantly...

By Fight Aging!
ANGPT2 Encourages Blood-Brain Barrier Leakage and Consequent Neurodegeneration
News•Jan 26, 2026

ANGPT2 Encourages Blood-Brain Barrier Leakage and Consequent Neurodegeneration

Researchers have identified angiopoietin‑2 (ANGPT2) as a key driver of blood‑brain barrier (BBB) dysfunction in Alzheimer’s disease (AD). Transcriptomic data show ANGPT2 is markedly up‑regulated in human AD brains, and mouse models reveal that endothelial‑specific deletion of ANGPT2 lowers β‑amyloid...

By Fight Aging!
Nuclear Export of HMGB1 Drives Astrocyte Senescence
News•Jan 26, 2026

Nuclear Export of HMGB1 Drives Astrocyte Senescence

The study shows that high‑mobility group box‑1 (HMGB1) expression declines in astrocytes as they age, and astrocyte‑specific HMGB1 knockout accelerates mouse aging. Nuclear HMGB1 acts as an anti‑senescence factor, while extracellular HMGB1 functions as a pro‑senescent, inflammatory signal. By inhibiting...

By Fight Aging!
Hemoglobin in the Progression of Aging
News•Jan 26, 2026

Hemoglobin in the Progression of Aging

Hemoglobin, traditionally viewed as the body’s oxygen carrier, also modulates inflammation, oxidative stress, and vascular health, all of which influence aging trajectories. In older adults, anemia is linked to frailty, cognitive impairment, higher hospitalization rates, and mortality, while elevated hemoglobin...

By Fight Aging!
Epoxy-Oxylipins as a Potential Means to Reduce Chronic Inflammation
News•Jan 23, 2026

Epoxy-Oxylipins as a Potential Means to Reduce Chronic Inflammation

Researchers have identified soluble epoxide hydrolase (sEH) inhibition as a means to boost epoxy‑oxylipin levels, notably 12,13‑EpOME and 14,15‑EET, in humans. Elevated epoxy‑oxylipins selectively reduce intermediate monocytes through p38 MAPK inhibition, accelerating pain resolution while leaving acute inflammatory markers largely...

By Fight Aging!

Page 2 of 3

← Prev123Next →